TY - JOUR
T1 - Decreased maternal-fetal attachment in methadone-maintained pregnant women
T2 - a preliminary study.
AU - Mikhail, M. S.
AU - Youchah, J.
AU - DeVore, N.
AU - Ho, G. Y.
AU - Anyaegbunam, A.
PY - 1995
Y1 - 1995
N2 - Maternal-fetal attachment represents the mother's affiliation and interaction with her unborn fetus. It develops during pregnancy and may be critical to successful mother-infant adaptation. The purpose of this study was to investigate maternal-fetal attachment in methadone-maintained pregnant women. We studied a cross-sectional sample of women (n = 67), 15 to 35 years of age, with uncomplicated, singleton pregnancies, at 28 to 37 weeks of gestation. The study population comprised two groups: group 1 consisted of 17 women enrolled in a substance abuse program who were using methadone, 40 to 80 mg a day, for a period of more than 3 months; group 2 included 50 women with no history of substance abuse. The Cranley 24-item scale was used as a measure of maternal-fetal attachment. Methadone-maintained pregnant women had diminished maternal-fetal attachment scores compared with controls (P < .05). This may be attributed to methadone use or to behavior characteristics of women with substance abuse. In either case, decreased maternal-fetal attachment may conceivably reduce women's compliance with prenatal health care, interfere with maternal adjustment during pregnancy, and/or have negative long-term effects on mother-child attachment.
AB - Maternal-fetal attachment represents the mother's affiliation and interaction with her unborn fetus. It develops during pregnancy and may be critical to successful mother-infant adaptation. The purpose of this study was to investigate maternal-fetal attachment in methadone-maintained pregnant women. We studied a cross-sectional sample of women (n = 67), 15 to 35 years of age, with uncomplicated, singleton pregnancies, at 28 to 37 weeks of gestation. The study population comprised two groups: group 1 consisted of 17 women enrolled in a substance abuse program who were using methadone, 40 to 80 mg a day, for a period of more than 3 months; group 2 included 50 women with no history of substance abuse. The Cranley 24-item scale was used as a measure of maternal-fetal attachment. Methadone-maintained pregnant women had diminished maternal-fetal attachment scores compared with controls (P < .05). This may be attributed to methadone use or to behavior characteristics of women with substance abuse. In either case, decreased maternal-fetal attachment may conceivably reduce women's compliance with prenatal health care, interfere with maternal adjustment during pregnancy, and/or have negative long-term effects on mother-child attachment.
UR - http://www.scopus.com/inward/record.url?scp=0029198547&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029198547&partnerID=8YFLogxK
M3 - Article
C2 - 7663100
AN - SCOPUS:0029198547
SN - 1048-9886
VL - 6
SP - 112
EP - 114
JO - Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians
JF - Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians
IS - 3
ER -